Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 1 June 2023.
Jump to navigation
Sofia, Bulgaria, June 1, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that at its meeting the Board of Directors decided to conduct a detailed analysis of potential opportunities for acquisition of shares in the capital of companies engaged in the production and/or marketing of medicinal products, food supplements, medical devices and/or other goods of importance to human health on the territory of the Republic of Serbia.